Kaya Hakki, Kutay Yıldırımlı Mustafa, Kurt Recep, Beton Osman, Birhan Yilmaz Mehmet
Departments of Cardiology, Cumhuriyet University Medical School, Sivas, Turkey.
Acta Cardiol Sin. 2017 May;33(3):292-300. doi: 10.6515/acs20160930a.
In this study, we investigated the relationship between the mean platelet volume (MPV) with mortality and heart failure (HF)-related hospitalization in stable chronic HF outpatients with reduced ejection fraction (HFrEF) and with sinus rhythm (SR).
This retrospective cohort study included 197 consecutive stable chronic HFrEF outpatients with SR, who were admitted to our cardiology outpatient clinics for examination between January 2014 and January 2015. According to the receiver-operating characteristic curve analysis, the optimal cut-off value of MPV to predict HF-related hospitalization was > 9.1 fL. Patients were classified into two categories according to threshold MPV levels, as group I with MPV ≤ 9.1 fL and group II with MPV > 9.1 fL.
The mean age of patients was 65 ± 13 years. The mean follow-up duration was 10 ± 3 months, and 44 patients (22%) succumbed to cardiovascular (CV) death. The rate of CV mortality was similar between the two groups (21% vs. 24%, p = 0.649). However, the rate of patients who experienced HF-related hospitalization was lower in group I compared with group II (41% vs. 87%, p < 0.001, respectively). Univariate analysis demonstrated associations of many clinical factors in addition to increased MPV > 9.1 fL with HF-related hospitalization; however, In the multivariate Cox proportional-hazards model, only increased MPV > 9.1 fL (HR: 2.895, 95% CI: 1.774-4.724, p < 0.001), systolic pulmonary artery pressure level (HR: 1.018, 95% CI: 1.001-1.036, p = 0.048) and pre-admission beta blocker use (HR: 0.517, 95% CI: 0.305-0.877, p = 0.014) remained associated with a risk of HF-related hospitalization.
The mean platelet volume might be a useful parameter for risk stratification with regard to HF-related hospitalization in HFrEF outpatients with SR.
在本研究中,我们调查了射血分数降低(HFrEF)且窦性心律(SR)的稳定慢性心力衰竭门诊患者的平均血小板体积(MPV)与死亡率及心力衰竭(HF)相关住院治疗之间的关系。
这项回顾性队列研究纳入了197例连续的患有SR的稳定慢性HFrEF门诊患者,这些患者于2014年1月至2015年1月期间入住我们的心脏病门诊进行检查。根据受试者工作特征曲线分析,预测HF相关住院治疗的MPV最佳截断值>9.1 fL。根据MPV阈值水平将患者分为两类,即MPV≤9.1 fL的I组和MPV>9.1 fL的II组。
患者的平均年龄为65±13岁。平均随访时间为10±3个月,44例患者(22%)死于心血管(CV)疾病。两组间CV死亡率相似(21%对24%,p = 0.649)。然而,I组发生HF相关住院治疗的患者比例低于II组(分别为41%对87%,p<0.001)。单因素分析表明,除了MPV>9.1 fL升高外,许多临床因素与HF相关住院治疗有关;然而,在多变量Cox比例风险模型中,只有MPV>9.1 fL升高(HR:2.895,95%CI:1.774 - 4.724,p<0.001)、收缩期肺动脉压水平(HR:1.018,95%CI:1.001 - 1.036,p = 0.048)和入院前使用β受体阻滞剂(HR:0.517,95%CI:0.305 - 0.877,p = 0.014)与HF相关住院治疗风险仍然相关。
对于患有SR的HFrEF门诊患者,平均血小板体积可能是HF相关住院治疗风险分层的一个有用参数。